Patient education programme | |
---|---|
1. | First meeting (during admission): Level of motivation, ambivalence, pros and cons |
2. | Second meeting (after 1 week): Dependence, withdrawal symptoms (experiences and expectations) |
3. | Third meeting (after 2 weeks): Relapse (description and management) |
4. | Fourth meeting (after 3 weeks): Benefits by short and long term alcohol abstinence |
5. | Fifth meeting (after 4 weeks): Continued alcohol abstinence or reduced intake following intervention |
At each meeting | |
• Thiamine and B-vitamins (300 mg × 7 weekly) | |
• Alcohol withdrawal prophylaxis and treatment (chlordiazepoxid 10 mg) | |
• DIS support (200 mg × 2 weekly) supervised at weekly meetings (not administrated if patients test positive on an alcohol breath test) | |
• Alcohol biomarkers (blood, urine and breath tests) | |
• ECG |